Fourth Frontier Frontier X Mobile Application, Frontier X2
Fourth Frontier Frontier X2 wearable lacks BLE authentication, allowing attackers to spoof devices and inject false
Summary
CISA disclosed CVE-2026-5768 affecting Fourth Frontier's Frontier X2 wearable device and mobile app, rated CVSS 8.8 (HIGH). The vulnerability allows unauthenticated Bluetooth Low Energy (BLE) read/write access to critical device functions without pairing authentication, enabling attackers within BLE range to manipulate device state, spoof devices, and inject fabricated health telemetry (heart rate, breathing rate, strain). The flaw affects all versions of Frontier X2, Android app <v15.0.0, and iOS app <v25.0.0.
Full text
ICS Medical Advisory Fourth Frontier Frontier X Mobile Application, Frontier X2 Release DateMay 28, 2026 Alert CodeICSMA-26-148-01 Related topics: Industrial Control System Vulnerabilities, Industrial Control Systems View CSAF Summary Successful exploitation of this vulnerability could allow an attacker to read and write arbitrary handle values and change clinical readings, which could result in taking control of the device and lead to patient harm. The following versions of Fourth Frontier Frontier X Mobile Application, Frontier X2 are affected: Frontier X Android application vers<v15.0.0 Frontier X IOS application vers<v25.0.0 Frontier X2 vers:all/* CVSS Vendor Equipment Vulnerabilities v3 8.8 Fourth Frontier Fourth Frontier Frontier X Mobile Application, Frontier X2 Missing Authentication for Critical Function Background Critical Infrastructure Sectors: Healthcare and Public Health Countries/Areas Deployed: Worldwide Company Headquarters Location: United States Vulnerabilities Expand All + CVE-2026-5768 The Frontier X2 device allows unauthenticated BLE read/write access to critical GATT characteristics without enforcing pairing authentication or authorization. This allows attackers within BLE range to perform unauthorized control of device functions, including starting/stopping activities, triggering vibrations, causing denial-of-service conditions, and fuzzing characteristic values to induce unexpected behavior. Additionally, the Frontier X mobile application lacks proper BLE device authentication, allowing attackers to impersonate a legitimate Frontier X2 device and connect to the application. By cloning BLE advertisements and exposing expected GATT characteristics, attackers can manipulate activity states and inject fabricated health telemetry such as breathing rate, heart rate, strain, and other health-related data into the mobile application. View CVE Details Affected Products Fourth Frontier Frontier X Mobile Application, Frontier X2 Vendor:Fourth Frontier Product Version:Fourth Frontier Frontier X Android application: <v15.0.0, Fourth Frontier Frontier X IOS application: <v25.0.0, Fourth Frontier Frontier X2: vers:all/* Product Status:known_affected Remediations MitigationFourth Frontier is aware of the vulnerability and is working on a fix. Users are encouraged to reach out to Fourth Frontier directly for assistance. https://fourthfrontier.com/pages/contact-usl.https://fourthfrontier.com/pages/contact-us MitigationFrontier X/X2 devices can connect to only one app at a time; users should first connect the Frontier X/X2 device using the Frontier X app and then start the activity. Relevant CWE: CWE-306 Missing Authentication for Critical Function Metrics CVSS Version Base Score Base Severity Vector String 3.1 8.8 HIGH CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H Acknowledgments Shakir Zari and Jerin Sunny reported this vulnerability to CISA Legal Notice and Terms of Use This product is provided subject to this Notification (https://www.cisa.gov/notification) and this Privacy & Use policy (https://www.cisa.gov/privacy-policy). Recommended Practices CISA recommends users take defensive measures to minimize the risk of exploitation of this vulnerability. Minimize network exposure for all control system devices and/or systems, ensuring they are not accessible from the internet. Locate control system networks and remote devices behind firewalls and isolating them from business networks. When remote access is required, use more secure methods, such as Virtual Private Networks (VPNs), recognizing VPNs may have vulnerabilities and should be updated to the most current version available. Also recognize VPN is only as secure as the connected devices. CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures. CISA also provides a section for control systems security recommended practices on the ICS webpage on cisa.gov/ics. Several CISA products detailing cyber defense best practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies. CISA encourages organizations to implement recommended cybersecurity strategies for proactive defense of ICS assets. Additional mitigation guidance and recommended practices are publicly available on the ICS webpage at cisa.gov/ics in the technical information paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies. Organizations observing suspected malicious activity should follow established internal procedures and report findings to CISA for tracking and correlation against other incidents. No known public exploitation specifically targeting this vulnerability has been reported to CISA at this time. This vulnerability is not exploitable remotely. Revision History Initial Release Date: 2026-05-28 Date Revision Summary 2026-05-28 1 Initial Publication Legal Notice and Terms of Use This product is provided subject to this Notification and this Privacy & Use policy. Tags Sector: Healthcare and Public Health Sector Topics: Industrial Control System Vulnerabilities, Industrial Control Systems Please share your thoughts We recently updated our anonymous product survey; we welcome your feedback. Related Advisories May 26, 2026 ICS Medical Advisory | ICSMA-26-146-01 Eppendorf BioFlo 320 Mar 24, 2026 ICS Medical Advisory | ICSMA-26-083-01 Grassroots DICOM (GDCM) Feb 10, 2026 ICS Medical Advisory | ICSMA-26-041-01 ZOLL ePCR IOS Mobile Application Dec 30, 2025 ICS Medical Advisory | ICSMA-25-364-01 WHILL Model C2 Electric Wheelchairs and Model F Power Chairs (Update A)
Indicators of Compromise
- cve — CVE-2026-5768